Paratek Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
PRTK Paratek Pharmaceuticals Inc
EGRAY Energy Resources Of Australia Ltd
IVAC Intevac Inc
AMPX Amprius Technologies Inc
PFE Pfizer Inc
BNOX Bionomics Ltd
CRKN Crown Electrokinetics Corp.
YMAB Y-mAbs Therapeutics Inc
VINE Fresh Vine Wine Inc

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. The Company's lead product, NUZYRA (omadacycline), is an oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia (CABP), and acute skin and skin structure infections (ABSSSI), caused by susceptible pathogens. Omadacycline is used in the emergency room, hospital, and community care settings. Its second product, SEYSARA (Sarecycline), is an oral therapy for the treatment of moderate to severe acne vulgaris.

Closing Price
Day's Change
0.42 (19.81%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

LyondellBasell to Discuss Fourth Quarter Results on Friday, February 3, 2023

6:30 am ET January 20, 2023 (PR Newswire) Print

LyondellBasell (NYSE: LYB), a leader in the global chemistry industry, will announce its fourth-quarter 2022 financial results before the U.S. market opens on Friday, February 3, followed by a webcast and teleconference to discuss the results at 11:00 a.m. ET.

Teleconference and Webcast DetailsFriday, February 3, 202311:00 a.m. ETHosted by David Kinney, Head of Investor RelationsAccess the webcast 10 to 15 minutes prior to the start of the call at

Toll-Free Teleconference Dial-In NumbersParticipant/Guest toll-free: 1-877-407-8029Participant/Guest toll: 201-689-8029Participant/Guest: CallMe link

Presentation SlidesPresentation slides will be available at the time of the teleconference and afterward at

Replay InformationA replay of the call will be available from 1:00 p.m. ET February 3 until March 3, 2023. The replay dial-in numbers are:Toll-Free: 1-877-660-6853Toll: 201-612-7415Access ID: 13734290

About LyondellBasell As a leader in the global chemical industry, LyondellBasell strives every day to be the safest, best operated and most valued company in our industry. The company's products, materials and technologies are advancing sustainable solutions for food safety, access to clean water, healthcare and fuel efficiency in more than 100 international markets. LyondellBasell places high priority on diversity, equity and inclusion and isAdvancing Goodwith an emphasis on our planet, the communities where we operate and our future workforce. The company takes great pride in its world-class technology and customer focus. LyondellBasell has stepped up its circularity and climate ambitions and actions to address the global challenges of plastic waste and decarbonization.In 2022, LyondellBasell was named as one of FORTUNE Magazine's "World's Most Admired Companies" for the fifth consecutive year. For more information, please visitwww.LyondellBasell.comor follow@LyondellBasellon LinkedIn.

View original content to download multimedia:

SOURCE LyondellBasell Industries

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.